Liege - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that at its Annual General Meeting, held today the appointment/renewal of the following Directors for a two-year mandate was approved.

The Board of Directors is now made up of 6 members with varied backgrounds spanning both the financial and pharmaceutical sectors, bringing extensive expertise to Mithra covering all aspects of pharmaceutical development.

The Board will include four new Directors, including: Ribono SRL, Mr. Sidney Bens (Independent Director)

Sidney is a seasoned financial executive, with over 35 years' experience. He spent most of his career at Atenor, an international real estate development company listed on Euronext, where he served as Chief Financial Officer. Prior to this he worked in banking, as Senior Corporate Banker at Paribas Bank Belgium (now Belfius) and in Retail and SMC banking at BBL (now ING). Sidney holds a Masters degree in Finance, Accounting and Trade from Lucien Cooremans Institute, Belgium and a Postgraduate in Finance from KU Leuven, Belgium.

Mrs. Igne Beernaert (Independent Director)

Igne is an experienced financial services professional, specializing in audit, corporate finance, internal controls, tax, management and M&A. She is the founder of Bedrijfsrevisor Beernaert, a financial advisory firm that provides audit, M&A and strategic financial consulting for growing companies, where she served as company auditor for the last 27 years. Prior to this, she founded bb3 Revisoren, another financial advisory firm. Igne holds a Masters degree in Applied Economics from KU Leuven, Belgium and a postgraduate degree in liability and insurance law from the University of Antwerp.

Life Science Strategy Consulting SRL, Mr. Christian Homsy (Independent Director)

Christian is a leading life sciences executive with over 30 years' industry experience. Most recently he founded and served as interim Chief Executive Officer and Board Member of biotechnology company Capstan Therapeutics. He was also founder, Chief Executive Officer and Board Member of Celyad SA for 15 years. He spent a large part of his career at Guidant Corporation (part of Boston Scientific and Abbott Labs) in a number of senior roles. Christian gained his Medical Doctorate at the University of Louvain, Belgium and his MBA at IMD Business School, Lausanne, Switzerland.

Gaudeto SRL, Mr. Jacques Galloy (Independent Director)

Jacques has over 25 years of business leadership experience including private and public equity capital markets, focusing on digital imaging, medical technology, digital media and digital transition. He is currently the founder and managing partner of Guadeto SPRL, an investment consultancy firm advising small to mid-size media, health technology and digital transition companies. He is a current investor in 7 companies, entrepreneur in 5 businesses and charities, and has over 10 board mandates. He also has 12 years' experience as Board member and CFO of EVS Broadcast Equipment SA, a worldwide leader in TV Technology niches and a top 30 Belgian listed company. Jacques holds a Masters in Commercial Engineering from Ulg-HEC Liege, Belgium.

David Horn Solomon, CEO, commented: ' It is fantastic to welcome such established and experienced professionals to the Mithra Board of Directors. Their collective knowledge spanning both the financial and life sciences sectors will be invaluable to the Company as we continue the commercialization of our lead product, Estelle and develop our exciting and innovative pipeline of products to address key unmet need.

The General Meeting also renewed the mandates of: Alius Modi SRL, Ms. Valerie Gordenne (Non-Executive Director)

Valerie has over 20 years of experience in pharmaceutical Research & Development with extensive leadership experience in full drug development across a range of therapeutic areas in particular in women's health (CSO Mithra, CEO Novalon, General Manager Odyssea). Through the management of various functions and activities, she has developed a deep operational and strategic knowledge in drug development. She is currently Chief Scientific Officer at Auxin Surgery, CEO of the start-up Odix and an advisor in regulatory affairs. She has a Masters in Pharmaceutical Science, University Of Liege, Belgium and a Masters in Industrial Pharmacy from Inter-University, Belgium.

Eva Consulting SRL, Prof. Jean-Michel Foidart (Executive Director)

Co-founder of Mithra, Jean-Michel is a trained doctor specializing in Obstetrics and Gynecology and is the author of more than 1300 publications on women's health and experimental oncology. He is a member of many national and international scientific committees and is currently a Board member of the International Society of Gynecological Endocrinology. Jean-Michiel holds the Francqui Chair, Doctor Honoris Causa of the Pierre and Marie Curie University of Paris and the Paul Sabatier University of Toulouse. Professor Extraordinary, Honorary of the ULg and Perpetual Secretary of the Royal Academy of Medicine of Belgium. Professor Foidart graduated in Gynecology from the University of Liege and also obtained a PhD in cell biology and biochemistry, before directing its Department of Gynecology-Obstetrics.

Contact:

Tel: +32 (0)4 349 28 22

Email: info@mithra.com

(C) 2023 Electronic News Publishing, source ENP Newswire